Recursion Pharmaceuticals Inc Clas (RXRX)

Other Income/Expenses (Net)

$3.96M

Quarterly · Period ending: · USD

RXRX logo

RXRX Other Income/Expenses (Net)

Latest reported$3.96M
RXRX Quarterly Other Income/Expenses (Net) (-$81.00K → $3.96M)
High-resolution chart · PNG

RXRX other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
3,962,000
6,397,000
232,000
9,952,000
4,330,000
-11,277,000
4,869,000
2,679,000
2,480,000
4,188,000
1,872,000
6,533,000
4,988,000
4,538,000
3,490,000
2,128,000
631,000
2,000
27,000
-1,026,000
-2,472,000
-233,000
-185,000
-1,399,000
-726,000
-81,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.